TherapeuticsMD Inc (TXMD)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$2.21-1.34%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · TXMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | |
|---|---|---|---|
| Revenues | |||
| Revenues | — | 3.0 | 1.8 |
| Total Revenues | — | — | 1.8 |
| Operating Expenses & Income | |||
| Selling, General & Admin | — | — | 4.7 |
| Operating Income | (4.0) | (4.4) | (4.8) |
| Earnings from Continuing Operations | |||
| Interest & Investment Income | — | 0.1 | — |
| Other Non-Operating Income / Expenses | 3.7 | 3.7 | 2.4 |
| EBT, Incl. Unusual Items | (0.3) | (0.7) | (2.3) |
| Income Tax Expense | — | — | (0.0) |
| Net Income | |||
| Net Income | (0.2) | (0.6) | (2.2) |
| Per Share | |||
| Basic EPS | (0.02) | (0.05) | (0.19) |
| Diluted EPS | (0.02) | (0.05) | (0.19) |
| Basic Weighted Avg Shares | 11.6 | 11.6 | 0.0 |
| Diluted Weighted Avg Shares | 11.6 | 11.6 | 0.0 |
| Supplemental | |||
| EBITDA | — | (4.0) | (4.3) |
| EBIT | (4.0) | (4.4) | (4.8) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.